EYPT EyePoint, Inc. - Common Stock
Acerca de EyePoint, Inc. - Common Stock Descripción general de la empresa de Wikipedia
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Leer más
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
EYPT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
EYPT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
EYPT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 7 35,0%
- Compra 12 60,0%
- Mantener 1 5,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
13 analistas · 2026-08-19Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-1.09 | $-0.97 | -0.12% |
| 31 de marzo de 2026 | $-0.99 | $-0.82 | -0.17% |
| 31 de diciembre de 2025 | $-0.81 | $-0.76 | -0.05% |
| 30 de septiembre de 2025 | $-0.85 | $-0.80 | -0.05% |
| 30 de junio de 2025 | $-0.85 | $-0.81 | -0.04% |
| 31 de marzo de 2025 | $-0.65 | $-0.67 | 0.02% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SPTX | — | — | — | — | — | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Balance general 27
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Flujo de Efectivo 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Balance general 27
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Flujo de Efectivo 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $31M | $43M | $46M | $41M | $37M |
| Margen Operativo % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Beneficio neto | $-232M | $-131M | $-71M | $-102M | $-58M |
| EPS Diluido | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | — | — | 0.0 | 0.4 | 0.2 |
| Ratio corriente | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Ratio Rápido | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-243M | $-130M | $-2M | $-67M | $-50M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 217 declarantes · $1.2B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 37 (-18 vs trimestre anterior) | 20 (-3 vs trimestre anterior) | 63 (-9 vs trimestre anterior) | 56 (+18 vs trimestre anterior) | +8.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118 638 163 | 8 296 375 | 10,19% | Acciones |
| Cormorant Asset Management, LP | $100 100 000 | 7 000 000 | 8,60% | Acciones |
| VANGUARD GROUP INC | $78 353 343 | 4 288 634 | 6,73% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69 037 426 | 4 827 792 | 5,93% | Acciones |
| Commodore Capital LP | $65 780 000 | 4 600 000 | 5,65% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $51 912 604 | 3 630 252 | 4,46% | Acciones |
| JANUS HENDERSON GROUP PLC | $45 962 750 | 3 565 768 | 3,95% | Acciones |
| Paradigm Biocapital Advisors LP | $41 332 677 | 2 890 397 | 3,55% | Acciones |
| STATE STREET CORP | $33 712 894 | 2 357 545 | 2,90% | Acciones |
| Aberdeen Group plc | $28 725 869 | 2 008 802 | 2,47% | Acciones |
| PERCEPTIVE ADVISORS LLC | $28 600 000 | 2 000 000 | 2,46% | Opción de venta |
| Balyasny Asset Management L.P. | $25 916 719 | 1 812 358 | 2,23% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $25 269 659 | 1 766 745 | 2,17% | Acciones |
| CITADEL ADVISORS LLC | $25 214 389 | 1 763 244 | 2,17% | Acciones |
| Parkman Healthcare Partners LLC | $18 420 731 | 1 288 163 | 1,58% | Acciones |
| EVENTIDE ASSET MANAGEMENT, LLC | $17 811 837 | 1 245 583 | 1,53% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $16 890 345 | 1 181 143 | 1,45% | Acciones |
| Essex Woodlands Management, Inc. | $15 513 455 | 1 084 857 | 1,33% | Acciones |
| ORBIMED ADVISORS LLC | $15 288 802 | 1 069 147 | 1,31% | Acciones |
| 5AM Venture Management, LLC | $15 015 000 | 1 050 000 | 1,29% | Acciones |
| Rosalind Advisors, Inc. | $14 131 689 | 988 230 | 1,21% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13 885 500 | 971 014 | 1,19% | Acciones |
| HSBC HOLDINGS PLC | $11 918 407 | 833 455 | 1,02% | Acciones |
| Candriam S.C.A. | $11 254 258 | 787 769 | 0,97% | Acciones |
| AMERIPRISE FINANCIAL INC | $11 087 640 | 775 357 | 0,95% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $11 062 981 | 773 635 | 0,95% | Acciones |
| Artia Global Partners LP | $10 969 501 | 767 098 | 0,94% | Acciones |
| Blue Owl Capital Holdings LP | $10 905 094 | 762 594 | 0,94% | Acciones |
| Patient Square Capital LP | $10 296 000 | 720 000 | 0,88% | Acciones |
| Principia Wealth Advisory, LLC | $9 696 346 | 530 725 | 0,83% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 260 866 | 647 613 | 0,80% | Acciones |
| Sio Capital Management, LLC | $8 910 759 | 623 130 | 0,77% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $7 996 789 | 559 216 | 0,69% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 899 320 | 552 400 | 0,68% | Opción de compra |
| Alyeska Investment Group, L.P. | $7 284 463 | 509 403 | 0,63% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 151 330 | 500 093 | 0,61% | Acciones |
| Simplify Asset Management Inc. | $5 720 629 | 400 044 | 0,49% | Acciones |
| Ikarian Capital, LLC | $5 296 720 | 370 400 | 0,46% | Opción de compra |
| Ikarian Capital, LLC | $5 296 720 | 370 400 | 0,46% | Opción de venta |
| Ghisallo Capital Management LLC | $5 005 000 | 350 000 | 0,43% | Acciones |
| STEMPOINT CAPITAL LP | $4 840 135 | 338 471 | 0,42% | Acciones |
| E Fund Management Co., Ltd. | $4 730 068 | 330 774 | 0,41% | Acciones |
| Jump Financial, LLC | $4 586 825 | 320 757 | 0,39% | Acciones |
| Bleichroeder LP | $4 526 165 | 316 515 | 0,39% | Acciones |
| Woodline Partners LP | $4 296 621 | 300 463 | 0,37% | Acciones |
| Eversept Partners, LP | $4 257 610 | 297 735 | 0,37% | Acciones |
| GOLDMAN SACHS GROUP INC | $4 086 797 | 285 790 | 0,35% | Acciones |
| Rock Springs Capital Management LP | $3 839 822 | 268 519 | 0,33% | Acciones |
| CITIGROUP INC | $3 750 032 | 262 240 | 0,32% | Acciones |
| MYDA Advisors LLC | $3 575 000 | 250 000 | 0,31% | Acciones |
| AXA Investment Managers S.A. | $3 480 640 | 244 427 | 0,30% | Acciones |
| UBS Group AG | $3 373 442 | 235 905 | 0,29% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3 342 639 | 233 751 | 0,29% | Acciones |
| Schonfeld Strategic Advisors LLC | $3 285 853 | 229 780 | 0,28% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 038 750 | 212 500 | 0,26% | Opción de venta |
| Propel Bio Management, LLC | $2 741 954 | 191 745 | 0,24% | Acciones |
| Qube Research & Technologies Ltd | $2 704 159 | 189 102 | 0,23% | Acciones |
| Walleye Capital LLC | $2 691 560 | 188 221 | 0,23% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $2 685 554 | 187 801 | 0,23% | Acciones |
| BlackRock, Inc. | $2 649 890 | 185 307 | 0,23% | Acciones |
| CITADEL ADVISORS LLC | $2 559 700 | 179 000 | 0,22% | Opción de venta |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2 389 303 | 169 334 | 0,21% | Acciones |
| HighVista Strategies LLC | $2 226 567 | 155 704 | 0,19% | Acciones |
| Granahan Investment Management, LLC | $2 136 234 | 149 387 | 0,18% | Acciones |
| Swiss National Bank | $2 034 890 | 142 300 | 0,17% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 998 711 | 139 770 | 0,17% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $1 890 660 | 132 214 | 0,16% | Acciones |
| Corient Private Wealth LP | $1 827 526 | 127 799 | 0,16% | Acciones |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1 740 081 | 121 684 | 0,15% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 548 690 | 108 300 | 0,13% | Opción de compra |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 548 690 | 108 300 | 0,13% | Opción de venta |
| DIADEMA PARTNERS LP | $1 520 090 | 106 300 | 0,13% | Opción de compra |
| SILVERBACK ASSET MANAGEMENT LLC | $1 430 000 | 100 000 | 0,12% | Opción de compra |
| Squarepoint Ops LLC | $1 401 429 | 98 002 | 0,12% | Acciones |
| RHUMBLINE ADVISERS | $1 393 341 | 97 437 | 0,12% | Acciones |
| CITADEL ADVISORS LLC | $1 357 070 | 94 900 | 0,12% | Opción de compra |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 354 752 | 105 101 | 0,12% | Acciones |
| ALGERT GLOBAL LLC | $1 129 557 | 78 990 | 0,10% | Acciones |
| Waverly Advisors, LLC | $1 114 170 | 77 914 | 0,10% | Acciones |
| Cinctive Capital Management LP | $1 037 923 | 72 582 | 0,09% | Acciones |
| Caption Management, LLC | $1 036 750 | 72 500 | 0,09% | Opción de compra |
| WELLINGTON MANAGEMENT GROUP LLP | $1 035 134 | 72 387 | 0,09% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 002 430 | 70 100 | 0,09% | Opción de compra |
| DEUTSCHE BANK AG\ | $989 860 | 69 221 | 0,09% | Acciones |
| Bank of New York Mellon Corp | $981 824 | 68 659 | 0,08% | Acciones |
| WOODSTOCK CORP | $979 049 | 68 465 | 0,08% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $971 081 | 75 336 | 0,08% | Acciones |
| BANK OF AMERICA CORP /DE/ | $930 186 | 65 048 | 0,08% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865 708 | 60 539 | 0,07% | Acciones |
| FOX RUN MANAGEMENT, L.L.C. | $836 950 | 58 528 | 0,07% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $732 017 | 51 190 | 0,06% | Acciones |
| SILVERBACK ASSET MANAGEMENT LLC | $715 000 | 50 000 | 0,06% | Acciones |
| JANE STREET GROUP, LLC | $715 000 | 50 000 | 0,06% | Opción de compra |
| Erste Asset Management GmbH | $705 500 | 50 000 | 0,06% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $702 545 | 49 129 | 0,06% | Acciones |
| Point72 Asset Management, L.P. | $694 608 | 48 574 | 0,06% | Acciones |
| SBI Okasan Asset Management Co.Ltd. | $644 827 | 45 700 | 0,06% | Acciones |
| MetLife Investment Management, LLC | $621 607 | 43 469 | 0,05% | Acciones |
| JANE STREET GROUP, LLC | $597 954 | 41 815 | 0,05% | Acciones |
| SCOTIA CAPITAL INC. | $597 039 | 41 751 | 0,05% | Acciones |
Informantes de la empresa 25 insiders · 12 directivos · 16 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 de julio de 2026 M | 9 594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12 de octubre de 2018 A | 211 700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18 de marzo de 2016 M | 450 741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 1 de agosto de 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 de septiembre de 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 de junio de 2026 M | 0 | 0 | 2 | $-73 174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22 de diciembre de 2018 M | 76 187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12 de octubre de 2018 F | 29 600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 de mayo de 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 de junio de 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 de julio de 2016 A | 96 423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 de octubre de 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Consejero | 18 de agosto de 2026 P | 49 100 | 1 | 0 | $52 258 |
| Wendy F Dicicco | Consejero | 2 de enero de 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Consejero | 2 de enero de 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Consejero | 2 de enero de 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Consejero | 15 de noviembre de 2018 M | 112 500 | 0 | 0 | $0 |
| John B. Landis | Consejero | 25 de octubre de 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Consejero | 6 de septiembre de 2018 A | 138 000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Consejero | 27 de junio de 2018 M | 12 500 | 0 | 0 | $0 |
| James J Barry | Consejero | 7 de mayo de 2018 M | 12 500 | 0 | 0 | $0 |
| Kristine Peterson | Consejero | 15 de diciembre de 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Consejero | 3 de diciembre de 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Consejero | 18 de diciembre de 2013 A | 10 000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Consejero | 27 de noviembre de 2007 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 presentaciones | 8 de diciembre de 2023 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 30 de agosto de 2023 | — | Presentación inicial | — | SEC |
| Ocumension Therapeutics | 22 de enero de 2021 | — | Presentación inicial | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 presentaciones | 26 de mayo de 2017 | — | Presentación inicial | — | SEC |
| Pfizer Inc. | 17 de julio de 2007 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 42 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11 564 NS | 30 de abril de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17 260 NS | 30 de abril de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 8 244 SH | 8 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,23% | 262 360 SH | 8 de agosto de 2026 | Diario |
| IHE · iShares Trust | 0,22% | 281 199 SH | 8 de agosto de 2026 | Diario |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25 180 NS | 31 de mayo de 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78 250 NS | 30 de abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 4 561 SH | 8 de agosto de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 86 797 SH | 8 de agosto de 2026 | Diario |
| BIB · ProShares Trust | 0,06% | 3 062 NS | 31 de mayo de 2026 | N-PORT |
| IWO · iShares Trust | 0,05% | 592 383 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 69 310 SH | 8 de agosto de 2026 | Diario |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25 575 NS | 31 de mayo de 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1 980 136 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,03% | 33 518 NS | 30 de abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 445 218 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61 360 SH | 8 de agosto de 2026 | Diario |
| ISCV · iShares Trust | 0,03% | 15 627 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,03% | 3 648 NS | 31 de mayo de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378 469 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34 174 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2 853 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152 391 NS | 30 de abril de 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 3 155 SH | 8 de agosto de 2026 | Diario |
| URTY · ProShares Trust | 0,01% | 2 885 NS | 31 de mayo de 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 120 933 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 901 417 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11 210 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 213 549 SH | 8 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 4 526 SH | 8 de agosto de 2026 | Diario |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2 895 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31 de mayo de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28 026 NS | 31 de mayo de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 564 NS | 30 de abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111 667 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 21 976 SH | 8 de agosto de 2026 | Diario |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46 188 NS | 31 de mayo de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 667 NS | 30 de abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41 879 NS | 30 de abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13 282 NS | 30 de abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 643 860 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 035 SH | 8 de agosto de 2026 | Diario |